DHI Price To Sales Ratio from 2010 to 2024

DHI Stock  USD 172.94  9.41  5.75%   
DR Horton's Price To Sales Ratio is increasing with slightly volatile movements from year to year. Price To Sales Ratio is estimated to finish at 6.16 this year. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing DR Horton's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
1.70805228
Current Value
6.16333799
Quarterly Volatility
1.32735634
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check DR Horton financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DR Horton's main balance sheet or income statement drivers, such as Depreciation And Amortization of 91.5 M, Interest Expense of 141.8 M or Selling General Administrative of 3.8 B, as well as many indicators such as Price To Sales Ratio of 6.16, Dividend Yield of 0.016 or PTB Ratio of 46.36. DHI financial statements analysis is a perfect complement when working with DR Horton Valuation or Volatility modules.
  
Check out the analysis of DR Horton Correlation against competitors.
For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.

Latest DR Horton's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of DR Horton over the last few years. Price to Sales Ratio is figured by comparing DR Horton stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on DR Horton sales, a figure that is much harder to manipulate than other DR Horton multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. DR Horton's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DR Horton's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 1.43 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

DHI Price To Sales Ratio Regression Statistics

Arithmetic Mean1.46
Geometric Mean1.23
Coefficient Of Variation91.15
Mean Deviation0.67
Median1.06
Standard Deviation1.33
Sample Variance1.76
Range5.4558
R-Value0.43
Mean Square Error1.54
R-Squared0.19
Significance0.11
Slope0.13
Total Sum of Squares24.67

DHI Price To Sales Ratio History

2024 6.16
2023 1.71
2022 1.03
2021 0.71
2020 1.09
2019 1.36
2018 1.12

About DR Horton Financial Statements

Investors use fundamental indicators, such as DR Horton's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although DR Horton's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Price To Sales Ratio 1.71  6.16 

Currently Active Assets on Macroaxis

When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:
Check out the analysis of DR Horton Correlation against competitors.
For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Household Durables space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.12)
Dividend Share
1.2
Earnings Share
14.34
Revenue Per Share
111.689
Quarterly Revenue Growth
(0.05)
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.